Pfizer’s Research & Development site in Sandwich, Kent, unveils new technology as it celebrates 20 years of clinical trial manufacturing.
Pfizer’s presence in Sandwich was first established nearly 65 years ago with the mass production of penicillin during World War II. Since then, the site has continued to evolve and in 1996 the Florey Chain House manufacturing facility officially opened.
Celebrating 20 years on, the facility unveiled two new pieces of equipment for controlled-release manufacturing technology, marking its commitment to continuously improve onsite capabilities in the search for the treatments of tomorrow.
Controlled-release technology allows researchers to alter the way the active ingredient is released and absorbed into the body, avoiding an initial spike as the medicine is delivered. Beyond the clinical benefits, this also means greater convenience for patients as it’s likely they won’t need to take their medicine as often during the day.1
Professor Trevor Jones CBE, former Director General of the Association of the British Pharmaceutical Industry (ABPI), joined Pfizer colleagues on 15th November to celebrate the facility’s manufacturing achievements and cut the ribbon to officially open the new equipment.
Located on the thriving Discovery Park campus, our research and development (R&D) site in Sandwich is home to over 700 colleagues scientists, technicians, regulatory professionals and business experts all working towards creating life-changing medicines for patients. The site is unique as it is home to Pfizer’s only fully automated Pilot Plant that manufactures medicines for use in Pfizer’s clinical trials worldwide.
Since starting operations over 20 years ago, it's estimated that Florey Chain House colleagues have tested 10,000 analytical samples, produced around 100 million solid-form medicines for use in clinical trials and sent over 50,000 shipments from the building's warehouse. With around 230 colleagues in the building today, the site continues to play a fundamental role in the drug discovery journey.
- Nokhodchi, A., Raja, S., Patel, P., & Asare-Addo, K. (2012). The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts : BI, 2(4), 175-87.
PP-PFE-GBR-4218 / November 2021